![[video] Digital Health Innovators: Does your solution qualify as Software as a Medical Device (SaMD)?](https://images.squarespace-cdn.com/content/v1/563c7acce4b028323896cb89/1630919850100-SJ68VGMR0T2FN758NSE0/SaMD+for+RPM+and+RTM_blog+image_NGL.png)
If you’re in the Remote Patient Monitoring (RPM) or Remote Therapeutic Monitoring (RTM) space, then you’ll want to understand the criteria and opportunities for qualifying as Software as a Medical Device (SaMD)
Read More
In a recent conversation with the tech news website Lifewire, Tommy Miller shared his take on whether smartwatches like the Apple watch could replace COVID testing in the near future.
Read More
With “Episode 3: 5 Tips from the Negotiation Table,” Tommy and I will dive into the following topics that should be relevant for every investor, founder, and CEO: Have a solid but flexible strategy/commercialization plan; Know and understand your competitive landscape, and how you will fit into/disrupt it.; Begin your company with the end in mind – preparing for exit; Be well-prepared in highly regulated industries (regulatory paths, documentation, marketing, information systems); What are your use cases and who is paying?
Read More
Join us as Tommy Miller, Sr. Counsel and Life Science Lead at Nixon Law Group, speaks with industry experts, John Lazo and Nikki Hastings, about how the global COVID-19 pandemic has impacted pharmaceutical drug development. The panel will discuss how innovators are responding to the pandemic through new tests, devices and therapeutics and how the drug development ecosystem can implement "lessons learned" to help us better prepare for the future of drug discovery.